Sterigmatocystin 10 mg | ≥98% LKT Laboratories, Inc. Mycotoxin produced by Aspergillus; carcinogen. More Information Supplier Page × Sterigmatocystin
Sterigmatocystin 5 mg | ≥98% LKT Laboratories, Inc. Mycotoxin produced by Aspergillus; carcinogen. More Information Supplier Page × Sterigmatocystin
Methotrexate Hydrate 500 mg | ≥98% LKT Laboratories, Inc. DHF reductase inhibitor. More Information Supplier Page × Methotrexate Hydrate
Methotrexate Hydrate 100 mg | ≥98% LKT Laboratories, Inc. DHF reductase inhibitor. More Information Supplier Page × Methotrexate Hydrate
Melanotan II 5 mg | ≥98% LKT Laboratories, Inc. Synthetis peptide, melanocortin analog; MCR agonist. More Information Supplier Page × Melanotan II
Suc-RGPF-pNA 1 mg | ≥98% LKT Laboratories, Inc. Peptide. More Information Supplier Page × Suc-RGPF-pNA
Meloxicam 1 g | ≥98% LKT Laboratories, Inc. NSAID; COX-2 inhibitor. More Information Supplier Page × Meloxicam
Suc-SDPF-pNA 10 mg | ≥98% LKT Laboratories, Inc. Peptide. More Information Supplier Page × Suc-SDPF-pNA
Meloxicam 500 mg | ≥98% LKT Laboratories, Inc. NSAID; COX-2 inhibitor. More Information Supplier Page × Meloxicam
Meloxicam 100 mg | ≥98% LKT Laboratories, Inc. NSAID; COX-2 inhibitor. More Information Supplier Page × Meloxicam
